Pelthos Therapeutics PTHS
NYSE PTHS
$21.50 +0.29 (+1.37%)
As of: Sep 30, 2026 · 3:55 PM EDT

Pelthos Therapeutics (PTHS) Receivables (2025 - 2026)

Updated

Pelthos Therapeutics (PTHS) reported Receivables of $14.48 million for Q2 2026, up 23.8% from the prior quarter.

Analysis

Pelthos Therapeutics (PTHS) Receivables (2025 - 2026) Analysis & Trends

At the end of FY2025, Pelthos Therapeutics posted Receivables of $8.86 million.

  • Per Business Quant data, the three quarters before Q2 2026 came in at $11.7 million (Q1 2026), $8.86 million (Q4 2025) and $7.99 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 19.05 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 13.82 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 12.56 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 9.64 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.68 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.23 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 5.06 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 12.49 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 2.13 Bn
10 Pelthos Therapeutics 78.87 Mn -9.52 Mn 11.99 Mn 14.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 14.48 Mn
Mar 31, 2026 11.70 Mn
Dec 31, 2025 8.86 Mn
Sep 30, 2025 7.99 Mn
API Access

Pelthos Therapeutics Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=PTHS&period=max&api_key=YOUR_API_KEY